Derma Sciences Regions Map

Select your location from over 190 countries where Derma Sciences operates.

Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement

Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement

Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement

Contract opens access of AMNIOEXCEL® and AMNIOMATRIX® to 3,400 new hospitals and 110,000 entities across the U.S.

Amniotic Tissue Products
Princeton, New Jersey

Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound care, announces that AMNIOEXCEL® and AMNIOMATRIX®, amniotic allografts derived from placental tissues, have been added to the Premier, Inc. Regenerative Skin Grafting contract portfolio. The announcement increases the opportunity for the AMNIOEXCEL® and AMNIOMATRIX® product lines, which continue to be adopted by clinicians in many health care facilities, including Veterans Administration and Military Hospitals, to be used in patient care.

“Amniotic tissue technology facilitates excellent clinical outcomes with difficult, non-healing wounds,” said Edward Eisenlord, Vice President of Corporate Accounts at Derma Sciences. “We are thrilled that more doctors and patients will benefit from access to these fairly priced advanced skin substitute products.” This new agreement offers Premier alliance members access to Derma Sciences’ complete amniotic allograft product line.
“Derma Sciences’ Amniotic Allograft products have shown impressive clinical results on my patients,” said Dr. Dimitrios Lintzeris, Wayne Memorial Hospital, Goldsboro, NC. “The ability to use AMNIOEXCEL® and/or AMNIOMATRIX®, depending on my patients’ wound management needs, is very beneficial to my practice.”

“This partnership with Premier, Inc. is an important milestone for our Amniotic Allograft product line as we continue to expand our presence as a leader in the tissue regeneration market,” said Barry Wolfenson, Group President, Advanced Wound Care and Product Development at Derma Sciences. “As industry front-runners, we are always looking for ways to expand access and reach more patients with our advanced treatment options. This partnership with Premier, Inc. will help us get there.”